Is Edesa Biotech Inc (EDSA) overvalued? · $64.2M cap
Edesa Biotech Inc (EDSA) is a biotechnology company listed on US.
This page asks whether Edesa Biotech Inc (EDSA) looks expensive on cached numbers — not a short thesis.
No cached income statement for EDSA, so there is no earnings base to call rich or cheap.
EDSA currently screens at market cap $64.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next EDSA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the EDSA stock page for the full model, not this heading.
Not investment advice.